Published in Am J Cardiol on May 01, 1983
Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction. Br Heart J (1985) 1.59
Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. Br Heart J (1984) 1.49
Effects of xamoterol (ICI 118,587) in asthmatic patients. Br J Clin Pharmacol (1984) 0.95
Clinical pharmacology and therapeutics. Postgrad Med J (1990) 0.84
Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle. Br Heart J (1989) 0.84
A comparative study on the ventilatory and haemodynamic effects of xamoterol and atenolol in asthmatic patients. Br J Clin Pharmacol (1986) 0.81
Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure. Br J Clin Pharmacol (1989) 0.78
Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure. Br J Clin Pharmacol (1989) 0.78
Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. Br J Clin Pharmacol (1985) 0.78
Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy. Br J Clin Pharmacol (1989) 0.78
Relationship between positive inotropic responses and plasma concentrations of xamoterol in middle-aged and elderly patients. Br J Clin Pharmacol (1990) 0.78
Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol. Br Heart J (1990) 0.75
The pharmacokinetics of xamoterol in liver disease. Br J Clin Pharmacol (1989) 0.75
Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function. Br J Clin Pharmacol (1989) 0.75
Long-term studies with xamoterol in heart failure. Br J Clin Pharmacol (1989) 0.75
Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease. Basic Res Cardiol (1989) 0.75
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet (1992) 7.22
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol (2000) 3.28
Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J (1995) 1.94
Histiocytosis X histogenetic arguments for a Langerhans cell origin. Biomedicine (1973) 1.90
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation (1992) 1.65
Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol (1996) 1.64
Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation. Eur J Clin Invest (1998) 1.60
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
Diagnostic value of history and maximal exercise electrocardiography in men and women suspected of coronary heart disease. Circulation (1977) 1.46
Diastolic function of the nonfilling human left ventricle. J Am Coll Cardiol (1992) 1.41
Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol (1990) 1.39
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet (2001) 1.34
Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim Biophys Acta (1996) 1.30
Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J (1989) 1.25
Antianginal effects of corwin, a new beta-adrenoceptor partial agonist. Am J Cardiol (1984) 1.22
Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J (1982) 1.16
Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem J (1992) 1.14
Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther (1994) 1.13
Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation (1980) 1.12
Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-igd and periodic fever syndrome: its application as a diagnostic tool. Ann Intern Med (2001) 1.11
The pathway of adenine nucleotide catabolism and its control in isolated rat hepatocytes subjected to anoxia. Biochem J (1982) 1.09
Adenylosuccinase deficiency: an inborn error of purine nucleotide synthesis. Eur J Pediatr (1988) 1.08
Coronary arteriography in acute transmural myocardial infarction. Am Heart J (1979) 1.05
Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail (2000) 1.04
Clinical, biochemical and molecular genetic correlations in adenylosuccinate lyase deficiency. Hum Mol Genet (2000) 1.03
Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease. Cardiovasc Res (1973) 1.03
ATP activates P2x-contracting and P2y-relaxing purinoceptors in the smooth muscle of mouse vas deferens. Br J Pharmacol (1992) 1.00
Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol (1983) 0.99
Inborn errors of the purine nucleotide cycle: adenylosuccinase deficiency. J Inherit Metab Dis (1997) 0.99
Effects of coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol (1979) 0.96
Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. J Cardiovasc Pharmacol (1992) 0.96
Mutation analysis in adenylosuccinate lyase deficiency: eight novel mutations in the re-evaluated full ADSL coding sequence. Hum Mutat (1999) 0.96
Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem J (1993) 0.95
Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure. Circulation (1980) 0.94
Residual adenylosuccinase activities in fibroblasts of adenylosuccinase-deficient children: parallel deficiency with adenylosuccinate and succinyl-AICAR in profoundly retarded patients and non-parallel deficiency in a mildly retarded girl. J Inherit Metab Dis (1993) 0.94
Stimulation by glycerate 2,3-bisphosphate: a common property of cytosolic IMP-GMP 5'-nucleotidase in rat and human tissues. Biochim Biophys Acta (1989) 0.92
Diagnostic value of exercise electrocardiography and thallium myocardial scintigraphy in patients without previous myocardial infarction: a Bayesian approach. Circulation (1981) 0.91
Diagnostic value of computerized exercise testing in men without previous myocardial infarction. A multivariate, compartmental and probabilistic approach. Eur Heart J (1985) 0.90
Coronary collaterals and left ventricular function early after acute transmural myocardial infarction. Eur Heart J (1982) 0.89
Metabolism of hypoxanthine in isolated rat hepatocytes. Biochem J (1984) 0.89
Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness. Circulation (1984) 0.89
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol (1994) 0.88
Surgical treatment of variant angina: use of plexectomy with aortocoronary bypass. Circulation (1980) 0.88
Light-induced conductivity changes in purple membrane suspensions. Biophys Struct Mech (1979) 0.87
Adenylosuccinate lyase deficiency: from the clinics to molecular biology. Adv Exp Med Biol (2000) 0.87
Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol. J Cardiovasc Pharmacol (1993) 0.87
Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease. Circulation (1988) 0.87
The purine nucleotide cycle and its molecular defects. Prog Neurobiol (1992) 0.86
Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure. J Cardiovasc Pharmacol (1992) 0.86
Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol (1984) 0.86
Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure. J Cardiovasc Pharmacol (1982) 0.86
Hemodynamic determinants of maximal oxygen intake in patients with healed myocardial infarction: influence of physical training. Circulation (1973) 0.86
Intracardiac angiotensin-converting enzyme inhibition improves diastolic function in patients with left ventricular hypertrophy due to aortic stenosis. Circulation (1994) 0.84
Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine. Circulation (1986) 0.84
Effects of asynchrony on myocardial relaxation at rest and during exercise in conscious dogs. Am J Physiol (1988) 0.84
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol (1987) 0.83
Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction. Circ Res (1987) 0.83
Effect of fructose on the concentration of phosphoribosylpyrophosphate in isolated hepatocytes. Adv Exp Med Biol (1986) 0.83
Functional studies in fibroblasts of adenylosuccinase-deficient children. J Inherit Metab Dis (1993) 0.83
Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris. Am J Cardiol (1981) 0.83
Cardiac mechanics during development of heart failure. SOLVD Investigators. Circulation (1993) 0.82
Changes in coronary blood flow and myocardial metabolism during aortic balloon valvuloplasty. Am J Cardiol (1988) 0.82
Inotropic drugs of the future. Eur J Clin Invest (1982) 0.82
Effects of alterations in aortic input impedance on the force-velocity-length relationship in the intact canine heart. Circ Res (1979) 0.82
Adenylosuccinase deficiency: possibly underdiagnosed encephalopathy with variable clinical features. Eur J Paediatr Neurol (1999) 0.82
Reassessment of the relation between QRS forces of the orthogonal electrocardiogram and left ventricular ejection fraction. Eur Heart J (1983) 0.81
Cytosolic purine 5'-nucleotidases of rat liver and human red blood cells: regulatory properties and role in AMP dephosphorylation. Adv Enzyme Regul (1988) 0.81
[Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Ann Med Interne (Paris) (1985) 0.81
Kemp-Vincent rally test of tennis skill. Res Q (1968) 0.81
Maximal exercise testing in patients with spontaneous angina pectoris associated with transiet ST segment elevation. Risks and electrocardiographic findings. Br Heart J (1975) 0.81
Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart. J Cardiovasc Pharmacol (1984) 0.81
[The value of xamoterol in moderate ischemic cardiac insufficiency]. Ann Cardiol Angeiol (Paris) (1984) 0.81
Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol (1984) 0.81
Prenatal diagnosis in adenylosuccinate lyase deficiency. Prenat Diagn (2000) 0.81
Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease. Postgrad Med J (1984) 0.81
Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload. J Cardiovasc Pharmacol (1983) 0.81
Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers. Peptides (2005) 0.81